Vor Biopharma Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 117.86 million compared to USD 92.09 million a year ago. Basic loss per share from continuing operations was USD 1.75 compared to USD 2.33 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.914 USD | +0.87% |
|
+0.11% | -59.33% |
Jul. 01 | Vor Biopharma Inc.(NasdaqGS:VOR) dropped from Russell 3000E Value Index | CI |
Jul. 01 | Vor Biopharma Inc.(NasdaqGS:VOR) dropped from Russell 2000 Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.33% | 61.85M | |
+17.79% | 44.63B | |
+43.57% | 40.46B | |
-9.11% | 38.07B | |
+33.17% | 32.27B | |
-8.98% | 27.3B | |
+14.64% | 26.53B | |
+45.17% | 14.06B | |
+32.25% | 12.54B | |
-8.57% | 11.28B |
- Stock Market
- Equities
- VOR Stock
- News Vor Biopharma Inc.
- Vor Biopharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023